---
title: "Lisuride - Acromegaly"
sidebar: mydoc_sidebar
permalink: db00589-mesh-d000172-1.html
toc: false 
---


Path ID: `DB00589_MESH_D000172_1`
{% include image.html url="images/db00589-mesh-d000172-1.png" file="db00589-mesh-d000172-1.png" alt="db00589-mesh-d000172-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:D008090 | Lisuride | Drug |
| UniProt:P14416 | D2 dopamine receptor | Protein |
| GO:0007195 | Adenylate cyclase-inhibiting dopamine receptor signaling pathway | BiologicalProcess |
| GO:0030252 | Growth hormone secretion | BiologicalProcess |
| MESH:D013006 | Growth Hormone | ChemicalSubstance |
| MESH:D000172 | Acromegaly | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Lisuride | INCREASES ACTIVITY OF | D2 Dopamine Receptor |
| D2 Dopamine Receptor | PARTICIPATES IN | Adenylate Cyclase-Inhibiting Dopamine Receptor Signaling Pathway |
| Adenylate Cyclase-Inhibiting Dopamine Receptor Signaling Pathway | NEGATIVELY REGULATES | Growth Hormone Secretion |
| Growth Hormone Secretion | INCREASES ABUNDANCE OF | Growth Hormone |
| Growth Hormone | CAUSES | Acromegaly |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB00589](https://go.drugbank.com/drugs/DB00589)
  - [https://link.springer.com/article/10.1007/s11102-016-0778-2](https://link.springer.com/article/10.1007/s11102-016-0778-2)

Reference: 
  - [https://go.drugbank.com/drugs/DB00589](https://go.drugbank.com/drugs/DB00589)
  - [https://link.springer.com/article/10.1007/s11102-016-0778-2](https://link.springer.com/article/10.1007/s11102-016-0778-2)
